Navigating the Complexities of Drug Pricing in the U.S.

This chapter explores the intricate challenges of the U.S. drug pricing system, focusing on individuals' struggles to afford medications. It highlights regulatory issues affecting companies like Gilead and critiques the systemic failures that hinder effective policy reforms in drug pricing.